NCT01055327 Birth Defects Associated With Exposure to Lamotrigine in Pregnancy (EUROCAT) Status COMPLETED Phase N/A
NCT01054885 Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT01053988 A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT01053507 Treximet for Prevention of Post Traumatic Headache Associated With Cognitive Dysfunction Status TERMINATED Phase PHASE4
NCT01052701 Drug Interaction Study With Ribavirin and Abacavir in Male Subjects With Hepatitis C Who Have Failed Ribavirin Treatment Status COMPLETED Phase PHASE1
NCT01051700 A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in Humans Status COMPLETED Phase PHASE1
NCT01051661 Safety and Efficacy of H1N1 Vaccines in Children Aged 6 Months to Less Than 10 Years of Age Status COMPLETED Phase PHASE3
NCT01051622 PBMC (Peripheral Blood Mononuclear Cells) /Lymphocyte SPECT (Single Photon Emission Computerized Tomography) Imaging in Crohn's Disease Status COMPLETED Phase PHASE1
NCT01051063 Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy Status COMPLETED Phase PHASE1
NCT01050322 Safety Study in Subjects With Metastatic Breast Cancer Who Progressed After Taxanes Treatment. Status COMPLETED Phase PHASE2
NCT01047397 Repeat Dose Safety and Efficacy Study for Compound to Treat Anemia Status COMPLETED Phase PHASE2
NCT01046604 Pilot Study of Lovaza (Omega 3 Fatty Acids) to Improve Cardiac Antioxidant/Anti-inflammatory Profile Before Cardiac Surgery Status UNKNOWN Phase PHASE4
NCT01046097 Post-marketing Surveillance Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Philippines Status TERMINATED Phase N/A
NCT01045590 Glibenclamide (Dose to be Titrated From Starting Dose of 5mg om) Plus Rosiglitazone 4mg om (Increased to 8mg om After 6 Months) and vs Glibenclamide (Dose to be Titrated With Starting Dose of 5mg om) Plus Placebo, Administered to Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT01045564 Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure Status WITHDRAWN Phase PHASE2